Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Ewing Sarcoma
100%
Transcriptional Targets
100%
EWS-FLI1
100%
SLFN11
100%
Sarcoma Cells
12%
Temozolomide
12%
Positive Regulator
12%
NCI-60
12%
PARP Inhibitors (PARPi)
12%
Breast Cancer
6%
Gene Expression
6%
In Cancer
6%
Binding Site
6%
Prostate Cancer
6%
Responsive Genes
6%
Targeted Therapy
6%
Overexpressing
6%
Colon Cancer
6%
Breast Cancer Cells
6%
Chromatin Immunoprecipitation (ChIP)
6%
Survival Rate
6%
Drug Sensitivity
6%
Cancer Cells
6%
Luciferase Reporter
6%
Therapeutic Response
6%
Knockdown
6%
High Sensitivity
6%
Topoisomerase Inhibitors
6%
Gene Drug
6%
Camptothecin
6%
Drug Response
6%
Pediatric Cancer
6%
Transcription Start Site
6%
ETS Transcription Factors
6%
FLI1
6%
Chimeric Transcription Factor
6%
Tumor-free Survival
6%
Leukemia Cancer
6%
ETS1
6%
Reporter Gene Analysis
6%
Inhibitor Combination
6%
Determinants of Response
6%
Clinical Tumour Samples
6%
Biochemistry, Genetics and Molecular Biology
Ewing Sarcoma
100%
FLI1
100%
Promoter Region
33%
Transcription Factors
22%
Cancer Cell
22%
Poly ADP Ribose Polymerase
22%
Binding Site
11%
Luciferase
11%
Survival Rate
11%
Gene Expression
11%
Chromatin Immunoprecipitation
11%
Drug Sensitivity
11%
Colon
11%
Drive
11%
Drug Response
11%
Transcription Initiation Site
11%
DNA Topoisomerase
11%
Topoisomerase
11%
ETS1
11%
Targeted Therapy
11%
Pediatrics
11%